Last week, NHS Scotland spending watchdogs approved a tablet, finerenone, for type 2 diabetes patients living with kidney disease and a decision is being made about England and Wales.
Since last year, these patients have been able to access five anti-Covid drugs which prevent them from falling seriously ill and ending up in hospital, but last week, four of the drugs were axed.